SCHOTT Pharma AG & Co. KGaA

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1.51% vs 7.47% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -18.80% vs 51.98% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "247.90",
          "val2": "251.70",
          "chgp": "-1.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.40",
          "val2": "62.30",
          "chgp": "-6.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.00",
          "val2": "4.80",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.10",
          "val2": "38.30",
          "chgp": "-18.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "147.40%",
          "val2": "171.70%",
          "chgp": "-2.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "986.20",
          "val2": "957.10",
          "chgp": "3.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "255.30",
          "val2": "237.90",
          "chgp": "7.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.70",
          "val2": "13.20",
          "chgp": "49.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "147.00",
          "val2": "150.30",
          "chgp": "-2.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "178.40%",
          "val2": "180.60%",
          "chgp": "-0.22%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

247.90

251.70

-1.51%

Operating Profit (PBDIT) excl Other Income

58.40

62.30

-6.26%

Interest

4.00

4.80

-16.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

31.10

38.30

-18.80%

Operating Profit Margin (Excl OI)

147.40%

171.70%

-2.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -1.51% vs 7.47% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -18.80% vs 51.98% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

986.20

957.10

3.04%

Operating Profit (PBDIT) excl Other Income

255.30

237.90

7.31%

Interest

19.70

13.20

49.24%

Exceptional Items

0.00

0.00

Consolidate Net Profit

147.00

150.30

-2.20%

Operating Profit Margin (Excl OI)

178.40%

180.60%

-0.22%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results